Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa

NCT02384460 is registered in ClinicalTrials.gov with Scioderm, Inc. as lead sponsor.

NCT NCT02384460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02384460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa
Lead sponsor
Scioderm, Inc.
Phase
Phase 3
Overall status
Completed
Start date
March 11, 2015
Completion date
July 5, 2017
Enrollment
169 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

epidermolysis bullosa